Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Andrew D. Bowser

News

OSA diagnoses not carried forward to the inpatient setting

Author:
Andrew D. Bowser
Publish date: October 26, 2020

Missed OSA diagnoses could have especially negative implications for patients who don’t continue on positive airway pressure (PAP) therapy during...

  • Read More

News

Switching to riociguat effective for some patients with PAH not at treatment goal

Author:
Andrew D. Bowser
Publish date: October 23, 2020

The clinical benefit of the switching to the sGC inhibitor was consistent across patient subgroups in the phase 4 REPLACE study.

  • Read More

News

Certain statins linked to lower mortality risk in patients admitted for sepsis

Author:
Andrew D. Bowser
Publish date: October 22, 2020

Statin use was associated with lower mortality, compared with no use, with hydrophilic and synthetic statins besting lipophilic and fungal-derived...

  • Read More

News

COVID-19 experience forced residents to quickly improve patient communication skills

Author:
Andrew D. Bowser
Publish date: October 21, 2020

At the peak of the pandemic in New York City, goals of care discussions became easier, though coping with death remains an issue.

  • Read More

News

National lung cancer screening guidelines may miss younger African American individuals at high risk

Author:
Andrew D. Bowser
Publish date: October 19, 2020

Retrospective analysis finds many lung cancer patients would not have counted as eligible for low-dose CT under guidelines that are being...

  • Read More

News

Fauci: Cautious optimism for COVID-19 vaccine by end of 2020

Author:
Andrew D. Bowser
Publish date: October 18, 2020

Top health official is “cautiously optimistic” for vaccine distribution before end of year, pending favorable safety and efficacy data.

  • Read More

News

COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate

Author:
Andrew D. Bowser
Publish date: September 16, 2020

No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments...

  • Read More

News

ctDNA clearance tracks with PFS in NSCLC subtype

Author:
Andrew D. Bowser
Publish date: July 13, 2020

The median progression-free survival was significantly longer for patients with circulating tumor DNA clearance.

  • Read More

News

Cognitive deficits complex in youths with type 2 diabetes

Author:
Andrew D. Bowser
Publish date: July 1, 2020

Average fluid cognition scores were significantly lower versus youths with type 1 diabetes, a difference investigators said was due to further...

  • Read More

News

Tiragolumab plus atezolizumab active in PD-L1+ NSCLC

Author:
Andrew D. Bowser
Publish date: June 30, 2020

The combination produced a response rate of 46%.

  • Read More

News

Lipid-lowering drugs appear to decrease risk of colorectal cancer death across subgroups

Author:
Andrew D. Bowser
Publish date: June 29, 2020

The risk of death was reduced regardless of age, sex, race, or duration of lipid-lowering drug use.

  • Read More

News

Personalized cancer vaccine may enhance checkpoint inhibitor activity

Author:
Andrew D. Bowser
Publish date: June 25, 2020

Combining a personalized vaccine, RO7198457, with atezolizumab produced many immune responses but few clinical...

  • Read More

News

Diabetes-related amputations on the rise in older adults

Author:
Andrew D. Bowser
Publish date: June 23, 2020

The finding reflects increases in diabetes-related nontraumatic lower extremity amputation occurring in younger U.S. population, but at a less...

  • Read More

News

Normal-weight prediabetes patients also benefit from lifestyle intervention

Author:
Andrew D. Bowser
Publish date: June 23, 2020

Fasting plasma glucose normalized in over 60%, suggesting normal-weight individuals should not be excluded from...

  • Read More

News

Frequent hypoglycemic episodes raise cardiac event risk

Author:
Andrew D. Bowser
Publish date: June 17, 2020

It’s “essential” to avoid drugs associated with hypoglycemia to minimize CV event risk in patients with type 2 diabetes, investigator says.

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close